Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Mechanical Support & Haemodynamics with Dr Frederick Welt
Author(s): Frederick Welt Added: 1 month ago
Learn about haemodynamic guidance in cardiogenic shock, including early intervention, device selection, and exit strategies, from Dr Frederick Welt (University of Utah, US)This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr… View more

Heart Failure

Intervention
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 1 week ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
Procedural Steps of TMVR Using Dedicated Mitral Devices with Dr Guerrero
Author(s): Mayra Guerrero Added: 1 week ago
Gain essential insights into the pivotal trials and procedural techniques shaping transcatheter mitral valve replacement with Dr Mayra GuerreroThis presentation, part of Women As One's comprehensive Structural Interventions track, provides timely analysis of the landmark SUMMIT and ENCIRCLE trials that are defining the future of dedicated mitral devices.Drawing from clinical trial data showing… View more

Intervention
Patient Selection for TMVR Devices with Dr Ignacio Inglessis-Azuaje
Author(s): Ignacio Inglessis-Azuaje Added: 1 week ago
Navigate the complexities of patient selection and device matching in TMVR with Dr Ignacio Inglessis-AzuajeThis presentation, part of Women As One's comprehensive Structural Interventions track, provides essential guidance for clinicians approaching this rapidly evolving field. The presentation systematically explores general eligibility requirements including symptomatic severity, surgical risk… View more

Intervention
Device Therapies in Heart Failure
Author(s): Yoel Benarroch , Natalie Tapaskar , Amin Yehya Added: 1 month ago

Heart Failure

Intervention
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 3 weeks ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
ESC 25: SWEDEPAD 1 and 2
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 2 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more

Intervention

Vascular Disease and Surgery
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 1 year ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
THT 2025: GSN Ablation in HFpEF
Author(s): Marat Fudim Added: 8 months ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more

Heart Failure
Management of Venous Thromboembolism
Author(s): Nazli Okumus , Ashley Park , Eugene Yuridistky , et al Added: 11 months ago

Anticoagulation

Vascular Disease and Surgery